News
(RTTNews) - Eton Pharmaceuticals Inc. (ETON) announced Tuesday that it has out-licensed commercial rights to Increlex in territories outside of the U.S. to Esteve Pharmaceuticals, S.A. Esteve will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results